Identify the right experts, build meaningful relationships, and drive compliant stakeholder engagement.
Table of Contents
Chapter 1. Core Principles and Strategic Framework for KOL Engagement
1.1 What KOL Mapping and Engagement Must Achieve
1.2 Differences Among KOLs, Experts, Influencers, and Stakeholders
1.3 The Role of KOLs Across the Product Lifecycle
1.4 Common Failure Modes in KOL Engagement Programs
1.5 KOL Mapping and Engagement Diagnostic Checklist
Chapter 2. Defining the KOL Strategy and Engagement Objectives
2.1 Linking KOL Strategy to Medical, Clinical, and Market Objectives
2.2 Defining the Scientific, Therapeutic, and Geographic Scope
2.3 Prioritizing Stakeholder Groups and Engagement Use Cases
2.4 Establishing Governance, Roles, and Decision Rights
2.5 Building the KOL Strategy Brief
Chapter 3. KOL Identification, Data Sources, and Evidence Gathering
3.1 Building the Initial Universe of Potential KOLs
3.2 Using Publications, Trials, Guidelines, Congresses, and Networks
3.3 Integrating Field Medical, Clinical, and Commercial Input
3.4 Validating Profiles and Avoiding Data Quality Issues
3.5 KOL Identification Workflow and Source Checklist
Chapter 4. KOL Segmentation and Prioritization
4.1 Defining Segmentation Criteria and Scoring Logic
4.2 Assessing Scientific Influence, Clinical Reach, and Network Position
4.3 Segmenting Global, National, Regional, and Emerging KOLs
4.4 Prioritizing KOLs by Strategic Relevance and Engagement Need
4.5 KOL Segmentation Matrix and Prioritization Template
Chapter 5. KOL Profiling and Insight Development
5.1 Creating Actionable KOL Profiles
5.2 Capturing Scientific Interests, Evidence Gaps, and Collaboration Fit
5.3 Mapping Relationships, Affiliations, and Influence Networks
5.4 Identifying Advocacy, Neutrality, Skepticism, and Unmet Needs
5.5 KOL Profile Template and Insight Summary Format
Chapter 6. KOL Engagement Planning and Execution
6.1 Designing KOL Engagement Plans by Segment
6.2 Selecting Appropriate Engagement Channels and Formats
6.3 Coordinating Medical, Clinical, Regulatory, and Commercial Touchpoints
6.4 Managing Engagement Cadence, Ownership, and Follow-Up
6.5 KOL Engagement Plan Template and Field Execution Checklist
Chapter 7. Compliance, Fair-Market Value, and Documentation
7.1 Core Compliance Principles for KOL Engagement
7.2 Fair-Market Value Basics for KOL Activities
7.3 Managing Contracts, Approvals, Payments, and Transparency Reporting
7.4 Documenting Legitimate Need, Scientific Purpose, and Outcomes
7.5 Compliance Review Checklist and Documentation Standards
Chapter 8. Implementation Roadmap and External Support Options
8.1 Building the KOL Mapping and Engagement Implementation Roadmap
8.2 Internal Capabilities, Tools, Governance, and Change Management
8.3 Support From Large Consulting Firms and Life Sciences Advisory Teams
8.4 Specialist Medical Affairs, Compliance, Data, and KOL Analytics Advisors
8.5 Independent Management Consultants Through Umbrex
